 |
|
***Search other cases***
Ackermann v. Wyeth Pharmaceuticals
| Topic(s): |
Preemption of Consumer Remedies
|
| Date Of Involvement: |
09/28/2006 |
| Description: |
In 2002, the FDA reversed its longstanding position that federal regulation does not preempt damages claims against phramaceutical companies. Immediately thereafter, pharmaceutical companies began routinely to argue that the Food, Drug, and Cosmetic Act impliedly preempts state-law actions brought by patients who have been injured by prescription drugs. These briefs were filed in support of the plaintiffs in two cases addressing that preemption issue. The issue was later resolved by the Supreme Court in the plaintiffs' favor in Wyeth v Levine. |
Because Public Citizen does not accept funds from corporations, professional associations or government agencies,
we can remain independent and follow the truth wherever it may lead. But that means we
depend on the generosity of concerned citizens like you for the resources to fight on
behalf of the public interest. If you would like to help us in our fight,
click here.
|
|
